Acceptance and timeliness of standard vaccination in children with chronic neurological deficits in north-western Switzerland

European Journal of Pediatrics

Volumn 164, Issue 5, 2005, Pages 320-325

  Tillmann, Bettina Ute ^a   Tillmann, Hanns Christian ^a,b   Heininger, Ulrich ^a   Lütschg, Jürg ^a   Weber, Peter ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b Biomit Inc   (Switzerland)

Author keywords

Chronic neurological deficit; Immunisation; Vaccination; Vaccination age; Vaccination rate

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; PERTUSSIS VACCINE; POLIOMYELITIS VACCINE; TETANUS TOXOID;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HEALTH BEHAVIOR; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; NEUROLOGIC DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SWITZERLAND; VACCINATION;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MALE; NERVOUS SYSTEM DISEASES; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; SWITZERLAND; VACCINATION;

EID: 18044387167     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-005-1627-x     Document Type: Article

References (23)

1. Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, Mullooly JP et al (2001) Centers for Disease Control and Prevention Vaccine Safety Datalink Working Group: the risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med 345: 656-661
2. Brody M, Sorley RG (1947) Neurologic complications following administration of pertussis vaccine. NY State J Med 47: 1016-1017
3. Bundesamt für Gesundheit der Schweiz (Swiss Federal Health Bureau) (1999) Repräsentative Erhebung zur Durchimpfung in der Schweiz 1998. Bulletin 20: 356-361
4. Campbell JR, Szylagyi PG, Rodewald LE, Winter NL, Humiston SG, Roghmann KJ (1994) Intent to immunize among pediatric and family residents. Arch Pediatr Adolesc Med 148: 926-929
5. Center for Disease Control and Prevention (2001) National, state, and urban area vaccination coverage levels among children age 19-35 months - United States 2000. JAMA 286: 1169-1170
6. Cherry JD (1990) Pertussis vaccine encephalopathy: it is time to recognize it as the myth that it is. JAMA 263: 1679-1680
7. Committee on Infectious Diseases (1991) The relationship between pertussis vaccine and brain damage: reassessment. Pediatrics 88: 397-400
8. Davis RL, Rubanowice D, Shinefield HR, Lewis N, Gu D, Black SB et al (1999) Immunization levels among premature and low birth-weight infants and risk factors for delayed up-to-date immunization status. JAMA 282: 547-553
9. Desgrandchamps D (1998) Routine vaccination schedule in childhood. Ther Umsch 55: 8-12
10. Fenichel GM (1999) Assessment: neurologic risk of immunization: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 52: 1546-1552
11. Grand MG, Wyll SA, Gehlbach SH, Landrigan PJ, Judelsohn RG, Zendel SA et al (1972) Clinical reactions following rubella vaccination. A prospective analysis of joint, muscular, and neuritic symptoms. JAMA 220: 1569-1572
12. Heininger U (2001) Recent progress in clinical and basic pertussis research. Eur J Pediatr 160: 203-213
13. Howson CP, Fineberg HV (1992) The ricochet of magic bullets: summary of the Institute of Medicine Report, adverse effects of pertussis and rubella vaccines. Pediatrics 89: 318-324
14. Kempe A, Steiner JF, Renfrew BL, Lowery E, Haas K, Berman S (2001) How much does a regional immunization registry increase documented immunization rates at primary care sites in rural Colorado? Ambul Pediatr 1: 213-216
15. Lauberau B, Hermann M, Schmitt HJ, Weil J, von Kries R (2002) Detection of delayed vaccinations: a new approach to visualize vaccine uptake. Epidemiol Infect 128: 185-92
16. MacKay IR, Rosen FS (2001) Vaccines and vaccination. N Engl J Med 345: 1042-10537
17. Madsen T (1933) Vaccination against whooping cough. JAMA 101: 187-188
18. Meszaros JR, Asch DA, Baron J, Hershey JC, Kunreuther H, Schwartz-Buzaglo J (1996) Cognitive processes and the decisions of some parents to forego pertussis vaccination for their children. J Clin Epidemiol 49: 697-703
19. Ovetchkine P (2001) Secondary effects of vaccinations. Arch Pediatr 8: 316-320
20. Patja A, Davidkin I, Kurki T, Kallio MJ, Valle M, Peltola H (2000) Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J 19: 1127-1134
21. Szylagyi PG, Rodewald LE, Humiston SG, Hager J, Roghmann KJ, Doane C et al (1994) Immunization practices of pediatricians and family physicians in the United States. Pediatrics 94: 517-523
22. Tillmann BU, Tillmann HC, Nars PW, Weber P (2001) Vaccination rate and age of premature infants < 1500 g in northwestern Switzerland. Acta Paediatr 90: 1421-1426
23. Vivier PM, Alario AJ, Peter G, Leddy T, Simon P, Mor V (2001) An analysis of the immunization status of preschool children enrolled in a statewide Medicaid managed care program. J Pediatr 139: 624-629